Medtronic PLC (NYSE:MDT) was downgraded by equities research
analysts at BTIG Research from a “buy” rating to a “neutral” rating in a
research note issued on Wednesday, The Fly reports.
Shares of Medtronic PLC (NYSE:MDT) opened at 80.48 on
Wednesday. The stock has a market capitalization of $112.76 billion and a
price-to-earnings ratio of 47.51. The firm’s 50-day moving average is $79.65
and its 200-day moving average is $76.88. Medtronic PLC has a 52 week low of
$55.54 and a 52 week high of $82.00.
Medtronic PLC (NYSE:MDT) last announced its quarterly
earnings data on Tuesday, May 31st. The medical technology company reported
$1.27 EPS for the quarter, beating the Zacks’ consensus estimate of $1.26 by
$0.01. During the same quarter in the previous year, the business posted $1.16
earnings per share. The firm earned $7.57 billion during the quarter, compared
to the consensus estimate of $7.49 billion. The firm’s quarterly revenue was up
3.6% on a year-over-year basis. On average, equities research analysts
anticipate that Medtronic PLC will post $4.37 EPS for the current fiscal year.
Source: American Banking and Market News